Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Specificity Evaluation of the SRI B. Anthracis Lethal Factor Diagnostic System

NCT05672875 is registered in ClinicalTrials.gov with SRI International as lead sponsor.

NCT NCT05672875
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05672875 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Specificity Evaluation of the SRI B. Anthracis Lethal Factor Diagnostic System
Lead sponsor
SRI International
Phase
Observational
Overall status
Terminated
Start date
January 23, 2023
Completion date
April 20, 2023
Enrollment
343 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

anthrax